MacroGenics
MGNX
#8310
Rank
A$0.43 B
Marketcap
A$6.79
Share price
1.95%
Change (1 day)
227.24%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07211. In 2024 the company made an earnings per share (EPS) of A-$1.54 a decrease over its 2023 EPS that were of A-$0.22.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-87.16%
2024A-$1.54613.33%
2023A-$0.22-92.31%
2022A-$2.81-42.14%
2021A-$4.8636.44%
2020A-$3.56-21.84%
2019A-$4.56-24.58%
2018A-$6.04675.93%
2017A-$0.78-68.05%
2016A-$2.44168.25%
2015A-$0.91-55%
2014A-$2.023400%
2013A-$0.05769-108.68%
2012A$0.6624.49%
2011A$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.89-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.71-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.88-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.88-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.13-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.13-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.55 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA